Reconstruction of the Corneal Epithelium with Induced Marrow Mesenchymal Stem Cells in Rats
Overview
Molecular Biology
Ophthalmology
Affiliations
Purpose: To explore the feasibility of bone marrow mesenchymal stem cells (MSCs) transdifferentiating into corneal epithelial cells in a limbal stem cell deficiency (LSCD) model in rats.
Methods: Rat MSCs were isolated and purified using a gradient isolation procedure. The cells were induced by rat corneal stromal cells (CSCs) in a transwell co-culture system. The induced MSCs were identified by immunofluorescence staining, flow cytometry, and scanning electron microscopy (SEM). A corneal LSCD model was produced in the right eyes of 48 rats by alkali injury. The eyes of 12 rats without any transplant served as controls (Group 1). Amniotic membranes (AM; Group 2), uninduced MSCs (Group 3), or MSCs induced by CSCs (Group 4), were transplanted onto the cornea of the model (n=12 each). The therapeutic effects of the four groups were evaluated by slit lamp observation, hematoxylin and eosin staining, immunohistochemistry staining, and confocal laser corneal microscopy.
Results: Cultivated MSCs were positive for CD29, CD44, and CD90, but negative for CD34, CD45, CD133, and CK12, with typical MSCs characteristics revealed by SEM. After co-culture with CSCs, the induced MSCs expressed positive staining for CK12 with corneal epithelial cell characteristics confirmed by SEM; the induced MSCs were unchanged on the amnion. Compared with the other three groups, the corneal opacity, fluorescence staining, and neovascularization grades were significantly decreased in the induced MSCs group, both on postoperative week four and ten.
Conclusion: MSCs induced by CSCs can transdifferentiate into corneal epithelial cells in vitro. The induced MSCs on an amniotic membrane have remarkable effects on the treatment of corneal alkali burn and the reconstruction of the corneal surface of rats.
Biomedical Application of MSCs in Corneal Regeneration and Repair.
De Miguel M, Cadenas-Martin M, Stokking M, Martin-Gonzalez A Int J Mol Sci. 2025; 26(2).
PMID: 39859409 PMC: 11766311. DOI: 10.3390/ijms26020695.
Hermankova B, Javorkova E, Palacka K, Holan V Cell Transplant. 2025; 34:9636897241312798.
PMID: 39856809 PMC: 11760125. DOI: 10.1177/09636897241312798.
Kobal N, Marzidovsek M, Schollmayer P, Malicev E, Hawlina M, Marzidovsek Z Int J Mol Sci. 2024; 25(20).
PMID: 39456906 PMC: 11507649. DOI: 10.3390/ijms252011121.
Focus on seed cells: stem cells in 3D bioprinting of corneal grafts.
Xie Z, Yuan B, Chi M, Hong J Front Bioeng Biotechnol. 2024; 12:1423864.
PMID: 39050685 PMC: 11267584. DOI: 10.3389/fbioe.2024.1423864.
Regulatory T Cells: Therapeutic Opportunities in Uveitis.
Lee A, Foulsham W Front Ophthalmol (Lausanne). 2024; 2:901144.
PMID: 38983511 PMC: 11182269. DOI: 10.3389/fopht.2022.901144.